These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1975309)

  • 41. Specificity of hepatitis C antibody ELISA in patients with haemophilia.
    Colombo M; Rumi MG; Mannucci PM
    Lancet; 1990 Jun; 335(8701):1345. PubMed ID: 1971404
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunoglobulins and hepatitis C virus.
    Thomas DP
    Lancet; 1990 Jun; 335(8704):1531. PubMed ID: 1972462
    [No Abstract]   [Full Text] [Related]  

  • 43. False-positive anti-HCV tests in rheumatoid arthritis.
    Theilmann L; Blazek M; Goeser T; Gmelin K; Kommerell B; Fiehn W
    Lancet; 1990 Jun; 335(8701):1346. PubMed ID: 1971406
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of antibody to delta hepatitis virus in population groups in West Germany and Switzerland.
    Frösner GG; Franco E; Altorfer J; Decker RH; Mushahwar IK
    Eur J Clin Microbiol; 1985 Apr; 4(2):147-9. PubMed ID: 3924603
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease.
    Sansonno D; Dammacco F
    Lancet; 1989 Sep; 2(8666):798-9. PubMed ID: 2571030
    [No Abstract]   [Full Text] [Related]  

  • 46. [Incidence of hepatitis C virus antibodies in blood donors, high risk patient groups, liver diseases and health professionals. Multicenter study of the ABBOT ELISA method, comparison with the ORTHO test].
    Pár A
    Orv Hetil; 1991 May; 132(18):955-9. PubMed ID: 1902928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
    Renger FG; Raabe A; Forster H; Knot E
    Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838
    [No Abstract]   [Full Text] [Related]  

  • 48. Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease.
    Gray JJ; Wreghitt TG; Friend PJ; Wight DG; Sundaresan V; Calne RY
    Lancet; 1990 Mar; 335(8689):609-10. PubMed ID: 1968606
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibodies to hepatitis C virus in Cuban blood donors.
    Rivero RA; Hedalgo-Gato R; Martinez M; Hernandez P; Ballester JM; Yamaguchi K; Fukuyoshi Y; Kiyokawa T; Takatsuki K
    Vox Sang; 1992; 63(4):285-6. PubMed ID: 1282758
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group.
    Irving WL; Neal KR; Underwood JC; Simmonds PN; James V
    BMJ; 1994 Mar; 308(6930):695-6. PubMed ID: 8142794
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
    Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
    Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
    Héjjas M; Medgyesi G; Hajnal A
    Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.
    Colombo M; Kuo G; Choo QL; Donato MF; Del Ninno E; Tommasini MA; Dioguardi N; Houghton M
    Lancet; 1989 Oct; 2(8670):1006-8. PubMed ID: 2572740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Primary carcinoma of the liver and hepatitis C virus in Italy. A prospective study in patients with cirrhosis].
    Bargiggia S; Piva A; Sangiovanni A; Donato F
    Medicina (Firenze); 1989; 9(4):424-6. PubMed ID: 2561301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.
    Garson JA; Tedder RS; Briggs M; Tuke P; Glazebrook JA; Trute A; Parker D; Barbara JA; Contreras M; Aloysius S
    Lancet; 1990 Jun; 335(8703):1419-22. PubMed ID: 1972209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies to hepatitis C virus.
    Roggendorf M; Deinhardt F; Rasshofer R; Eberle J; Hopf U; Möller B; Zachoval R; Pape G; Schramm W; Rommel F
    Lancet; 1989 Aug; 2(8658):324-5. PubMed ID: 2569116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.